Last reviewed · How we verify
Ginseng
At a glance
| Generic name | Ginseng |
|---|---|
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Plant Protein With Ashwagandha-Rhodiola for Sleep Quality (NA)
- Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial (NA)
- Weak Pulse at Yang and Wiry Pulse at Yin Theory (NA)
- Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma (PHASE4)
- A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery (NA)
- Effect of Korean Red Ginseng on Oxidation in Middle-aged and Elderly Sub-health Population (PHASE2, PHASE3)
- Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory and Cardiovascular Biomarkers in Healthy, Older Individuals. (NA)
- Wisconsin Ginseng for Decreasing Cancer Related Fatigue (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ginseng CI brief — competitive landscape report
- Ginseng updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI